Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice - Role of oxidativestress
S. Kinugawa et al., Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice - Role of oxidativestress, CIRCUL RES, 87(5), 2000, pp. 392-398
Oxidative stress might play an important role in the progression of left ve
ntricular (LV) remodeling and failure that occur after myocardial infarctio
n (MI), We determined whether reactive oxygen species (ROS) are increased i
n the LV remodeling and failure in experimental MI with the use of electron
spin resonance spectroscopy and whether the long-term administration of di
methylthiourea (DMTU), hydroxyl radical ((OH)-O-.) scavenger, could attenua
te these changes. We studied 3 groups of mice: sham-operated (sham), MI, an
d MI animals that received DMTU (MI + DMTU), Drugs were administered to the
animals daily via intraperitoneal injection for 4 weeks,(OH)-O-. was incre
ased in the noninfarcted myocardium from MI animals, which was abolished in
MI + DMTU. Fractional shortening was depressed by 65%, LV chamber diameter
was increased by 53%, and the thickness of noninfarcted myocardium was inc
reased by 37% in MI. MI + DMTU animals had significantly better LV contract
ile function and smaller increases in LV chamber size and hypertrophy than
MI animals. Changes in myocyte cross-sectional area determined with LV mid-
free wall specimens were concordant with the wall thickness data. Collagen
volume fraction of the noninfarcted myocardium showed significant increases
in the MI, which were also attenuated with DMTU, Myocardial matrix metallo
proteinase-2 activity, measured with gelatin zymography, was increased with
MI after 7 and 78 days, which was attenuated in MI + DMTU. Thus, the atten
uation of increased myocardial ROS and metalloproteinase activity with DMTU
may contribute, at least in part, to its beneficial effects on LV remodeli
ng and failure. Therapies designed to interfere with oxidative stress might
be beneficial to prevent myocardial failure.